Invention Grant
- Patent Title: Pharmaceutical salts of substituted-quinoxaline-type bridged-piperidine compounds
-
Application No.: US16705814Application Date: 2019-12-06
-
Publication No.: US11111246B2Publication Date: 2021-09-07
- Inventor: Jiangchao Yao , John W. F. Whitehead , Naoki Tsuno , Kouki Fuchino
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: Purdue Pharma L.P.
- Agent Weiving Yang
- Main IPC: C07D241/44
- IPC: C07D241/44 ; C07D471/08 ; C07D403/04 ; C07D451/14
Abstract:
The invention relates to Substituted-Quinoxaline-Type Bridged-Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.
Public/Granted literature
- US20200223847A1 SUBSTITUTED-QUINOXALINE-TYPE BRIDGED-PIPERIDINE COMPOUNDS AND THE USES THEREOF Public/Granted day:2020-07-16
Information query
